Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its
frequency in pediatric patients is 10–15%. For this reason, age is considered one of the …

Immunotherapy failures can result from the highly suppressive tumour microenvironment
that characterizes aggressive forms of cancer such as recurrent glioblastoma (rGBM),. Here …

Inhibition of the interaction between MDM2 and p53 has emerged as a promising strategy
for combating cancer, including the treatment of glioblastoma (GBM). Numerous MDM2 …

Importance The prognosis of overall survival (OS) in patients with glioblastoma (GBM) may
depend on the underlying structural connectivity of the brain. Objective To examine the …

An artificial intelligence (AI) model's performance is strongly influenced by the input features.
Therefore, it is vital to find the optimal feature set. It is more crucial for the survival prediction …

Automatic segmentation of intracranial brain tumors in three-dimensional (3D) image series
is critical in screening and diagnosing related diseases. However, there are various …

Glioblastoma (GBM) are among the most common malignant central nervous system (CNS)
cancers, they are relatively rare. This evidence suggests that the CNS microenvironment is …

Computed tomography (CT) is the first modern slice-imaging modality. Recent years have
witnessed its widespread application and improvement in detecting and diagnosing related …

Glioblastoma, as the most aggressive brain tumor, is associated with a poor prognosis and
outcome. To optimize prognosis and clinical therapy decisions, there is an urgent need to …

Gangliosides are highly abundant in the human brain where they are involved in major
biological events. In brain cancers, alterations of ganglioside pattern occur, some of which …